Vector Genome Integrity
Ensuring the integrity of AAV vector genomes is crucial for therapeutic efficacy. ONT’s long-read sequencing technology can detect and characterize structural variants, deletions, and insertions within the AAV genome, providing insights into vector stability and potency. This comprehensive analysis is pivotal for optimizing vector design and manufacturing processes.
Full-length Capsid Sequence Analysis
The AAV capsid, composed of viral proteins, determines tropism and immunogenicity. Eurofins Genomics long-read sequencing can sequence full-length capsid genes without fragmentation, allowing for the precise identification of mutations, recombinations, and variants that may impact vector performance and safety.
Epigenetic Modifications
Epigenetic modifications such as methylation can influence AAV vector expression and packaging. Eurofins Genomics direct sequencing service can detect these modifications in native DNA without the need for bisulfite conversion, providing a more accurate and detailed epigenetic profile of AAV vectors.